• Return to Headlines

2.4% Return Seen to Date on SmarTrend Endocyte Inc Call (ECYT)

By Amy Schwartz

SmarTrend identified an Uptrend for Endocyte Inc (NASDAQ:ECYT) on October 18th, 2018 at $23.44. In approximately 18 months, Endocyte Inc has returned 2.37% as of today's recent price of $23.99.

In the past 52 weeks, shares of Endocyte Inc have traded between a low of $23.39 and a high of $24.00 and are now at $23.99, which is 3% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has remained constant.

Endocyte Inc. operates as a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. The Company uses a proprietary technology to create small molecule drug conjugates, SMDCs, and companion imaging diagnostics that actively target receptors that are over-expressed on diseased cells and relative to healthy cells.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Endocyte Inc shares.

Log in and add Endocyte Inc (ECYT) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights endocyte inc

Ticker(s): ECYT